2020 annual financial data
Estrella Immunopharma 2020 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -733,693 USD and net income was -733,693 USD.
Operating cash flow was -670,820 USD.
Get free Estrella Immunopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -733,693 USD
- Net income
- -733,693 USD
- Operating cash flow
- -670,820 USD